The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediatingapoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway(ABP52199-3.02)
Date：2021-03-16
Views：276
